As of December 2024 Halozyme Therapeutics has a market cap of $6.04 Billion USD. This makes Halozyme Therapeutics the world's 2394th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Dec 23rd, 2024 the market cap of Halozyme Therapeutics was reported to be: